Preliminary results of the Spanish Association of Urology National Registry in Active Surveillance for prostate cancer

被引:0
作者
Rubio-Briones, J. [1 ]
Borque, A. [2 ]
Esteban, L. M. [3 ]
Iborra, I. [1 ]
Lopez, P. A. [4 ]
Gil, J. M. [2 ]
Pallas, Y. [5 ]
Fumado, Ll. [6 ]
Martinez-Breijo, S. [7 ]
Chantada, V. [7 ]
Gomez, E. [8 ]
Quicios, C. [9 ]
Congregado, C. B. [10 ]
Medina, R. [10 ]
Ortiz, M. [11 ]
Montesino, M. [12 ]
Clar, F. [13 ]
Soto, J. [14 ]
Campa, J. M. [15 ]
机构
[1] Inst Valenciano Oncol, Valencia, Spain
[2] Hosp Univ Miguel Servet, Zaragoza, Spain
[3] Escuela Univ Almunia, Zaragoza, Spain
[4] Hosp Virgen Arrixaca, Murcia, Spain
[5] Hosp Manises, Valencia, Spain
[6] Hosp del Mar, Barcelona, Spain
[7] Hosp Juan Canalejo, La Coruna, Spain
[8] Hosp Univ Reina Sofia, Cordoba, Spain
[9] Fdn Jimenez Diaz, E-28040 Madrid, Spain
[10] Hosp Univ Virgen del Rocio, Seville, Spain
[11] Hosp Gen Univ Elche, Alicante, Spain
[12] Complejo Hosp Navarra, Pamplona, Spain
[13] Hosp Ribera, Valencia, Spain
[14] Hosp Univ Puerta Mar, Cadiz, Spain
[15] Hosp Univ Araba, Alava, Spain
来源
ACTAS UROLOGICAS ESPANOLAS | 2016年 / 40卷 / 01期
关键词
Prostate cancer; Active surveillance; Multicentre studies; Prognosis; Information; QUALITY-OF-LIFE; MEN; SCORE;
D O I
10.1016/j.acuroe.2015.11.002
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To present a National Registry of patients with prostate cancer as monitored through active surveillance, with the intention of testing the hypothesis that cancer-specific mortality in very low-risk and low-risk patients is less than 5% at 15 years. Material and methods: A multicentre observational study (AEU-PIEM/2014/0001) sponsored by the Spanish Association of Urology was conducted using their platform for multicentre studies. The clinical-pathological inclusion criteria were as follows: cT1a-cT3a, PSA <= 20 ng/ml, initial minimum biopsy of 10 cores, number of affected cores <= 3, 1st Gleason score of 3 and 2nd Gleason score <= 4 and a known prostate volume (in cc). A unified follow-up was not established for all recruiting centres; however, a survey was conducted that reflects the follow-up characteristics based on a number of tangible parameters that allow for their comparison. With the same philosophy of flexibility, the use of certain biomarkers and multiparametric MRI was not considered necessary for inclusion. Results: We describe the Registry's characteristics and possibilities, as well as the preliminary results from the 324 patients included in its first 5 months of operation in the 15 recruiting centres. We also report the clinical-pathological variables, biomarkers, radiodiagnosis technique and quality-of-life questionnaires considered for the database, as well as the possibilities for indefinite follow-up, remaining open to any active treatment recognized in clinical guidelines. Conclusions: The AEU-PIEM/2014/0001 represents an extremely useful tool for all Spanish urologists for multicentre clinical research. The registry will undoubtedly enable the dissemination of active surveillance of our patients in a more coordinated manner, thus maintaining the advantages of optimised opportunistic screening for prostate cancer without resulting in overtreatment. (C) 2015 AEU. Published by Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 22 条
[1]   How Does Active Surveillance for Prostate Cancer Affect Quality of Life? A Systematic Review [J].
Bellardita, Lara ;
Valdagni, Riccardo ;
van den Bergh, Roderick ;
Randsdorp, Hans ;
Repetto, Claudia ;
Venderbos, Lionne D. F. ;
Lane, J. Athene ;
Korfage, Ida J. .
EUROPEAN UROLOGY, 2015, 67 (04) :637-645
[2]   Urology and Web predictive resources [J].
Borque, A. ;
Esparrago, M. ;
Sanchez-Martin, F. ;
Rubio-Briones, J. ;
Esteban, L. M. ;
Sanz, G. .
ACTAS UROLOGICAS ESPANOLAS, 2014, 38 (03) :141-142
[3]   Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study [J].
Bul, Meelan ;
Zhu, Xiaoye ;
Valdagni, Riccardo ;
Pickles, Tom ;
Kakehi, Yoshiyuki ;
Rannikko, Antti ;
Bjartell, Anders ;
van der Schoot, Deric K. ;
Cornel, Erik B. ;
Conti, Giario N. ;
Boeve, Egbert R. ;
Staerman, Frederic ;
Vis-Maters, Jenneke J. ;
Vergunst, Henk ;
Jaspars, Joris J. ;
Stroelin, Petra ;
van Muilekom, Erik ;
Schroder, Fritz H. ;
Bangma, Chris H. ;
Roobol, Monique J. .
EUROPEAN UROLOGY, 2013, 63 (04) :597-603
[4]   Active Surveillance for Prostate Cancer: Progress and Promise [J].
Cooperberg, Matthew R. ;
Carroll, Peter R. ;
Klotz, Laurence .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27) :3669-3676
[5]   National Prostate Cancer Registry 2010 in Spain [J].
Cozar, J. M. ;
Minana, B. ;
Gomez-Veiga, F. ;
Rodriguez-Antolin, A. ;
Villavicencio, H. ;
Cantalapiedra, A. ;
Pedrosa, E. .
ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (01) :12-19
[6]   Prostate cancer incidence and newly diagnosed patient profile in Spain in 2010 [J].
Cozar, Jose M. ;
Minana, Bernardino ;
Gomez-Veiga, Francisco ;
Rodriguez-Antolin, Alfredo ;
Villavicencio, Humberto ;
Cantalapiedra, Arancha ;
Pedrosa, Emilio .
BJU INTERNATIONAL, 2012, 110 (11B) :E701-E706
[7]   Active surveillance for the management of prostate cancer in a contemporary cohort [J].
Dall'Era, Marc A. ;
Konety, Badrinath R. ;
Cowan, Janet E. ;
Shinohara, Katsuto ;
Stauf, Frank ;
Cooperberg, Matthew R. ;
Meng, Maxwell V. ;
Kane, Christopher J. ;
Perez, Nanette ;
Master, Viraj A. ;
Carroll, Peter R. .
CANCER, 2008, 112 (12) :2664-2670
[8]   Active Surveillance for Prostate Cancer: A Systematic Review of the Literature [J].
Dall'Era, Marc A. ;
Albertsen, Peter C. ;
Bangma, Christopher ;
Carroll, Peter R. ;
Carter, H. Ballentine ;
Cooperberg, Matthew R. ;
Freedland, Stephen J. ;
Klotz, Laurence H. ;
Parker, Christopher ;
Soloway, Mark S. .
EUROPEAN UROLOGY, 2012, 62 (06) :976-983
[9]   Weighted Versus Unweighted Charlson Score to Predict Long-term Other-cause Mortality in Men with Early-stage Prostate Cancer [J].
Daskivich, Timothy J. ;
Kwan, Lorna ;
Dash, Atreya ;
Greenfield, Sheldon ;
Litwin, Mark S. .
EUROPEAN UROLOGY, 2014, 66 (06) :1002-1009
[10]  
Donovan J, 2003, Health Technol Assess, V7, P1